Click on one of these terms to refine your search
1 to 10 of 11 literature results
Mutations in TP53 underlie the development of malignant peripheral nerve sheath tumors (MPNSTs) in animal models, but there is controversy regarding t…
Authors: Robert M Verdijk, Michael A den Bakker, Hendrikus J Dubbink, Wim C J Hop, Winand N M Dinjens, Johan M Kros
Source: Journal of neuropathology and experimental neurology. 2010 Jan
View Full TextThe androgen receptor (AR) is a member of the steroid receptor family, a group of transcription factors that activate steroid-regulated genes. Live ce…
Authors: Pascal Farla, Remko Hersmus, Bart Geverts, Pierre O Mari, Alex L Nigg, Hendrikus J Dubbink, Jan Trapman, Adriaan B Houtsmuller
Source: Journal of structural biology. 2004 Jul
View Full TextAndrogen receptor (AR) transcriptional activity is tightly regulated by interacting cofactors and cofactor complexes. The best described cofactor inte…
Authors: Dennis J van de Wijngaart, Hendrikus J Dubbink, Michel Molier, Carola de Vos, Jan Trapman, Guido Jenster
Source: Molecular endocrinology (Baltimore, Md.). 2009 Nov
View Full TextOne mechanism of prostate tumors for escape from androgen ablation therapies is mutation of the androgen receptor (AR). We investigated the unique pro…
Authors: Dennis J van de Wijngaart, Michel Molier, Scott J Lusher, Remko Hersmus, Guido Jenster, Jan Trapman, Hendrikus J Dubbink
Source: The Journal of biological chemistry. 2010 Feb 12
View Full TextSteroid receptors regulate gene expression in a ligand-dependent manner by binding specific DNA sequences. Ligand binding also changes the conformatio…
Authors: Martin E van Royen, Sónia M Cunha, Maartje C Brink, Karin A Mattern, Alex L Nigg, Hendrikus J Dubbink, Pernette J Verschure, Jan Trapman, Adriaan B Houtsmuller
Source: The Journal of cell biology. 2007 Apr 9
View Free Full TextThe androgen receptor (AR) ligand-binding domain (LBD) binds FXXLF motifs, present in the AR N-terminal domain and AR-specific cofactors, and some LXX…
Authors: Hendrikus J Dubbink, Remko Hersmus, Ashley C W Pike, Michel Molier, Albert O Brinkmann, Guido Jenster, Jan Trapman
Source: Molecular endocrinology (Baltimore, Md.). 2006 Aug
View Full TextPURPOSE: O6-methylguanine-methyltransferase (MGMT) promoter methylation has been shown to predict survival of patients with glioblastomas if temozolom…
Authors: Martin J van den Bent, Hendrikus J Dubbink, Marc Sanson, Cathleen R van der Lee-Haarloo, Monika Hegi, Judith W M Jeuken, Ahmed Ibdaih, Alba A Brandes, Martin J B Taphoorn, Marc Frenay,…
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Dec 10
View Full TextPURPOSE: Recent studies have shown the prognostic significance of IDH1 mutations in glioma. It is yet unclear if IDH1 mutations are predictive for out…
Authors: Martin J van den Bent, Hendrikus J Dubbink, Yannick Marie, Alba A Brandes, Martin J B Taphoorn, Pieter Wesseling, Marc Frenay, Cees C Tijssen, Denis Lacombe, Ahmed Idbaih,…
Source: Clinical cancer research : an official journal of the American Association for Cancer Research. 2010 Mar 1
View Full TextUpon hormone binding, a hydrophobic coactivator binding groove is induced in the androgen receptor (AR) ligand-binding domain (LBD). This groove serve…
Authors: Dennis J van de Wijngaart, Martin E van Royen, Remko Hersmus, Ashley C W Pike, Adriaan B Houtsmuller, Guido Jenster, Jan Trapman, Hendrikus J Dubbink
Source: The Journal of biological chemistry. 2006 Jul 14
View Full TextAmong nuclear receptors, the androgen receptor (AR) is unique in that its ligand-binding domain (LBD) interacts with the FXXLF motif in the N-terminal…
Authors: Hendrikus J Dubbink, Remko Hersmus, Chandra S Verma, Hetty A G M van der Korput, Cor A Berrevoets, Judith van Tol, Angelique C J Ziel-van der Made, Albert O Brinkmann, Ashley C W Pike, Jan Trapman
Source: Molecular endocrinology (Baltimore, Md.). 2004 Sep
View Full Text